5-hydroxymethylcytosine has been researched along with Cognitive Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Guo, X; He, X; Li, D; Li, S; Pei, S; Zhang, T | 1 |
| Li, L; Li, W; Liu, Z; Miao, M; Qiu, Y; Wang, Q; Zhu, Y | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Cognitive Dysfunction
| Article | Year |
|---|---|
N-3 polyunsaturated fatty acids prevent the D-galactose-induced cognitive impairment by up-regulating the levels of 5-hydroxymethylcytosine in the mouse brain.
Topics: 5-Methylcytosine; Animals; Brain; Cognitive Dysfunction; Fatty Acids, Omega-3; Galactose; Mice; Neurodegenerative Diseases | 2022 |
Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2×Tg-AD mice.
Topics: 5-Methylcytosine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Differentiation; Cognitive Dysfunction; Dioxygenases; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Hippocampus; Histone Deacetylase 1; Humans; Learning; Mice; Mice, Transgenic; Neural Stem Cells; Proto-Oncogene Proteins; RNA-Seq | 2020 |